U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"Radio has no future."

Lord Kelvin, British mathematician and physicist ; 1897

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 514/712 - Thioether


Subclass of Class 514 - Drug, bio-affecting and body treating compositions
Definition: Subject matter in which the compound has the R-S-R structure
No. of patents: 133
Last issue date: 08/24/2010


1        
NumberTitleIssue Date
7781488Post-cleavage sulfur deprotection for convergent protein synthesis by chemical ligation
The present invention provides a method and compositions for synthesizing an oligopeptide or polypeptide by convergent assembly of a plurality of pairs of oligopeptides in chemical ligation reactions. An important aspect of the present invention is an oligopeptide h...
08/24/2010
7759399Pharmaceutical compositions
A compound comprising a cyclopentanone, cyclopentenone, cyclohexanone or cyclohexenone group, wherein a first ring carbon atom carries an —SR substituent, R is a substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, aralkyl, aralkenyl, or aralkynyl group tha...
07/20/2010
7375252Compounds and method for the inhibition of the expression of VCAM-1
This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases. ...
05/20/2008
7361684Screening of compounds for treatment of atherosclerosis and heart attack
Transgenic animals that do not express functional SR-BI and ApoE develop severe atherosclerosis, by age four weeks in transgenic mice. Moreover, these animals exhibit progressive heart dysfunction by as early as age four weeks, and die by age nine weeks. This animal...
04/22/2008
7351745Compositions and methods of their use for improving the condition and appearance of skin
The present invention relates to compositions and methods for treating, preventing and improving the condition and/or aesthetic appearance of skin, particularly, treating, preventing, ameliorating, reducing and/or eliminating fine lines and/or wrinkles of skin, wher...
04/01/2008
7276631Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
The present disclosure relates to chemical compounds and their use in human therapy. A specific embodiment of the disclosure relates to compounds of Formula (I); or an isomer, a pharmaceutically acceptable salt or solvate thereof or a pharmaceutically acceptable for...
10/02/2007
7273948Process of preparing esters and ethers of probucol and derivatives thereof
A probucol or a probucol derivative can be efficiently converted to a monoester or monoether of probucol by reacting the free hydroxyl-containing probucol or a derivative thereof (by which is meant a probucol compound with at least one substituent that is different ...
09/25/2007
7135550Three hybrid assay system
The invention provides compositions and methods for isolating ligand binding polypeptides for a user-specified ligand, and for isolating small molecule ligands for a user-specified target polypeptide using an improved class of hybrid ligand compounds. ...
11/14/2006
7128908Methods for treating systemic lupus erythematosus using anti-TNF antibodies and fragments thereof
Anti-TNF antibodies, fragments and regions thereof which are specific for human tumor necrosis factor-α (TNFα) and are useful in vivo diagnosis and therapy of a number of TNFα-mediated pathologies and conditions, as well as polynucleotides coding for murine and c...
10/31/2006
7119123Antimicrobially active 4-methyl-4-aryl-2-pentanols, their preparation and use
Antimicrobially active 4-methyl-4-aryl-2-pentanols of the Formula 1 below, methods for the preparation of these compounds and their use as antimicrobial active compounds are described. Surprisingly, compounds of th...
10/10/2006
RE39197Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mammal....
07/18/2006
7067500Betaines as adjuvants to susceptibility testing and antimicrobial therapy
The present invention is directed to methods of antimicrobial therapy for a patient infected with, or suspected of being infected with a microorganism that has mycolic acid structures in its outer membrane, said method comprising coadministering a betaine-like deter...
06/27/2006
7014864Formulations comprising lipid-regulating agents
The present invention is directed to a formulation comprising a lipid-regulating agent dissolved in at least one structured lipid as the primary solvent medium for said agent. One or more emulsifiers may be added to the formulation. ...
03/21/2006
6930125Airway alkalinization as a therapy for airway diseases
The present invention relates to a method of treating asthma by raising the pH of the airways of an individual. The effect can be mediated directly by administering a pharmaceutically acceptable basic solution or alternatively, the effect can be mediated by enhancin...
08/16/2005
6878700Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immunune diseases, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immune response in a mamma...
04/12/2005
6867203Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases and cerebral vasospasm, to pharmaceutical compositions containing these compounds, and to methods of inhibiting inflammation or suppressing immun...
03/15/2005
6812257Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
Polysubstituted indan-1-ol compounds of formula I, its physiologically acceptable salts and physiologically functional derivatives are disclosed Compositions comprising the same, methods of preparation and methods for ...
11/02/2004
6608061Bisaryl compound and medicament for cancer treatment comprising the same
A medicament for treatment of cancer comprising a compound represented by the following general formula (I) or a physiologically acceptable salt thereof: Ar1 --S--R1 --S--Ar2 wherein R1 represents a nonmetal bridging...
08/19/2003
6602914Compounds and methods for the inhibition of the expression of VCAM-1
This invention is in the area of methods and compositions for the inhibition of the expression of VCAM-1 and, in particular, for the treatment of diseases mediated by VCAM-1, including cardiovascular and inflammatory diseases....
08/05/2003
6500416Pesticide
There are described a flowable composition for controlling harmful insects and representatives of the order Acarina, comprising at least one pesticidally active compound, one or more signal substances selected from the group consisting of pheromones, kair...
12/31/2002
6498196Compounds useful in pain management
The present invention relates to novel thio-aminotetralin compounds of the formula (I) ##STR1## wherein Z, X, R1, R2, R3, R4, R5, and R6 are defined herein. The compounds are useful in pain...
12/24/2002
6495152Sulfur containing polyhydroxyalkanoate compositions and method of production
A class of biopolymer including sulfur in the form of a thioester in the polymer backbone or a thioether in the polymer side chains has been developed. These are preferably produced by fermentation of bacteria with appropriate sulfur containing substrates...
12/17/2002
6465421Modulating body/cranial hair growth
The growth of body and/or head/cranial hair on mammalian organisms, for example humans, is modulated by administering thereto, whether topically and/or systemically, therapeutically effective amounts of at least one lipoxygenase or cyclooxygenase inhibito...
10/15/2002
6444709Heteroethylene compounds and pharmaceutical and cosmetic compositions containing same
The invention relates to novel heteroethynylenic compounds having the general formula (I): ##STR1## as well as to the use of these compounds in pharmaceutical compositions intended for use in human or veterinary medicine (dermatological, rheumatic, r...
09/03/2002
6291441Method of treating inflammatory bowel disorders
This invention relates to a method of treating patients suffering from the inflammatory bowel disorders. The method includes administering to a patient in need of treatment an effective amount of a thiol or reducible disulfide compound according to the fo...
09/18/2001
6239111In vivo method of improving survival rate of brain neurons
The present invention discloses the use, in the manufacture of a preventive and therapeutic drug of a brain disease, of a compound represented by formula (1): [wherein R represents a hydrogen atom, an alkyl group, an alkenyl group, a substituted alkyl gro...
05/29/2001
6217914Ascorbic acid composition and method for treatment of aging or damaged skin
An ascorbic acid-based composition and related method for the treatment of aging or photo-damaged skin is disclosed. The composition includes water and ascorbic acid, at least a portion of which has generally been pretreated by being dissolved under relat...
04/17/2001
6218431Substituted biphenyls
Substituted biphenyls having glucagon receptor antagonistic activity. Claimed compounds have the formula ##STR1## wherein R1a and R1b independently represent (C1 -C6) alkyl; R2 represents (C1
04/17/2001
6214887Vascular remodeling agent
Probucol exerts a positive effect on vascular remodeling. By using probucol to promote vascular remodeling by the method of the invention, favorable results can be obtained in treating such diseases and conditions as restenosis following transluminal coro...
04/10/2001
6177469Lipid alcohols as new immunosuppressive and antiviral drugs
The present invention concerns new immunosuppressive and antiviral pharmaceutical agents using lipid alcohols of the general formulae I and II ##STR1## in which R1 represents a straight-chained or branched, saturated or unsaturated alkyl c...
01/23/2001
6162815RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof
Novel pharmaceutically/cosmetically-active polycyclic aromatic compounds having the structural formula (I): ##STR1## wherein Ar is a radical having one of the formulae (a)-(e): ##STR2## which are useful for the treatment of a wide variety of dis...
12/19/2000
6147122Propofol composition containing sulfite
Sterile pharmaceutical compositions for parenteral administration containing 2,6-diisopropylphenol (propofol) are described for use as anesthetics. The compositions comprise an oil-in-water emulsion of propofol additionally comprising an amount of sulfite...
11/14/2000
6143796Method for reducing development of free radical induced malignancies
This invention relates to a method of treating patients at risk of developing a free radical induced malignancy. The method includes administering an effective amount of a thiol or reducible disulfide compound according to the formula set forth in the spe...
11/07/2000
6121319Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
This invention is a method and composition for the inhibition of VCAM-1, and in particular for the treatment of cardiovascular or inflammatory disease, including atherosclerosis, that includes the administration of an effective amount of an ester of probu...
09/19/2000
6110922Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
The present invention relates to novel cinnamide compounds that are useful for treating inflammatory and immune diseases, to pharmaceutical compositions comprising these compounds, and to methods of inhibiting inflammation or suppressing immune response i...
08/29/2000
6106821Fly attractant compositions
The invention relates to fly attractant compositions that comprise at least one volatile short chain carboxylic acid, at least one organic sulfide and at least one nitrogen heterocycle. In a preferred embodiment the composition additionally comprises at l...
08/22/2000
6103753Intimal thickening inhibitory agent
An intimal thickening inhibitory agent comprising, as an active ingredient, a compound represented by formula (1): ##STR1## wherein X represents an oxygen atom or a group of formula (2): ##STR2## wherein n represents an integer of from 0 to 2, R...
08/15/2000
6080790Tri-substituted phenyl derivatives and processes for their preparations
Compounds of formula (1) ##STR1## are described wherein Y represents a halogen atom or a group --OR1, where R1 is an optionally substituted alkyl group; R2 represents an optionally substituted cycloalkyl or cycloalken...
06/27/2000
6043286Pesticidal compounds
Pesticidal as a pesticide against whitefly, Lepidoptera and certain fungi is provided of compound of general formula (I) ##STR1## or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R inde...
03/28/2000
5997874Dihydrophenanthrene
The present invention relates to a class of dihydrophenanthrene which are isolated from Calanthe discolor Lindl. and derivatives thereof....
12/07/1999
1        
 
Sign InRegister
Username  
Password   
forgot password?